ARCHIVES

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

This article is from The Cancer Letter archive.

Vol. 18 No. 38 | October 2, 1992

Download PDF Visit The Full Archive

Related Articles

ACS Asks $1.5 Billion for NCI; Waxman Considers Requiring NIH To Send Budget Directly To Congress

March 4, 1983

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

NCAB Supports NCI Director’s Call For Increase In Management Funds.

December 8, 2000

Judge Rules Privacy Act Not Applicable In Bernard Fisher’s Suit Against HHA

July 5, 1996

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

New Approach To Replacing Immune Cells Shrinks Tumors

September 27, 2002